Global Pet Diabetes Care Market Size, Trends and Growth Opportunity, By Animal Type, By Solution, By Distribution Channel, By Drug Type, By Region and Forecast till 2027.

Global Pet Diabetes Care Market Size, Trends and Growth Opportunity, By Animal Type, By Solution, By Distribution Channel, By Drug Type, By Region and forecast till 2027.

Global Pet Diabetes Care Market

Global Pet Diabetes Care Market is valued at USD 1.64 billion in 2021 and expected to reach at USD 2.46 billion by 2027 at a CAGR 5.20% from 2022-2027.

Diabetes Mellitus is one of the common and well-known metabolic diseases which have been identified in canine and feline family. Diabetic Dogs & Cats can live long & healthy lives with proper management and veterinary care. If any change is observed in pet’s behaviour or weight, it is advised to consult a veterinarian. Dogs & cats with diabetes generally need long-term treatment with special diet, good fitness regime, and especially in dog daily insulin injections. The key to managing diabetic pets is to maintain blood sugar near normal range and avoid too-high or too-low range which can be life threatening. Dogs & cats are less susceptible to atherosclerosis compared to humans, while diabetes is a relatively common endocrine disease in both dog & cat species.

Market Drivers Components such as rising companion animal population and pet adoption, availability of pet diabetes care instruments, the incidence and increasing risk factor of the diseases, encouraging awareness programmes initiated by government, and policy implemented by key companies are driving the growth of Pet Diabetes Care Market. Increasing cases of diabetes in pets is anticipated to create more opportunity for the market growth during the forecast period. Increase in adoption of pet animals is expected to grow the spending on the healthcare need of these animals that would in turn anticipated to boost the growth of the market in the upcoming years.

Market Restraints

The COVID-19 pandemic has resulted in decreased sales in the pet diabetes care market decline. This hampers a market due to lockdown declaration all over the world and respective restricted access to and closure of veterinary services. Lockdown makes a barrier between pet owners in getting better veterinary care owing to strict lockdown rules and regulations and cancellation of veterinary appointments that would lead to impede the market growth.

Market Segmentation

The Global Pet Diabetes Care Market is segmented into Animal, Type, Solution, Distribution Channel, Drug Type. By Animal such as Dogs, Cats. By Solution such as Treatment (Insulin Therapy, Insulin Delivery Devices, Other Treatments), Glucose Monitoring Devices. By Distribution Channel such as Veterinary Hospitals & Clinics, Retail Pharmacies, E-commerce. By Drug Type such as Insulin Therapy, Oral Medication.

Regional Analysis

The Global Pet Diabetes Market Care is segmented into five regions such as North America, Europe, Asia Pacific, Latin America, and MEA. North America held more than 30% of the earning share of the market in 2021. The high share of the region is due to remarkable presence of key players, the acceptance of various strategies launches by various companies to rise market penetration, rise in treatment availability, increasing diagnostic rate, and growing pet population and spendings. Europe region held second-largest profit share of the market for pet diabetes care in 2021. Asia Pacific is estimated to record a CAGR of over 9% from 2022-2030. This is because of increasing animal healthcare expenditure, rising demand for proper and timely diagnosis for pet diabetes in developing countries.

Key Players

Various Key Players are listed in this report such as Merck & Co., Inc., Zoetis, BD, Boehringer Ingelheim International GmbH, Trividia Health, Inc., Allison Medical, Inc., UltiMed, Inc., ACON Laboratories Inc., i-SENS, Inc., TaiDoc Technology Corporation.

Market Taxonomy

By Animal

• Dogs
• Cats

By Solution

• Treatment

Insulin Therapy

Insulin Delivery Devices

Other Treatments

• Glucose Monitoring Devices.

By Distribution Channel

• Veterinary Hospitals & Clinics
• Retail Pharmacies
• E-commerce.

By Drug Type

• Insulin Therapy
• Oral Medication.

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa.